What's New at CBER

You are subscribed to  What's New at CBER for the U.S. Food & Drug Administration (FDA)

What's New Today

The following links have been updated recently:

Posted: 4/1/2024

• Providing Regulatory Submissions in Electronic Format: IND Safety Reports; Guidance for Industry
• CBER Cures Vacancy Announcement – Branch Chief, AD-0696-Band D - Office of Compliance and Biologics Quality (OCBQ)/Division of Manufacturing and Product Quality (DMPQ)/Manufacturing Review Branch 1 (MRB1)
• CBER Title 21 Vacancy Announcement – Deputy Division Director, Band E, Office of Vaccines Research and Review (OVRR), Division of Review Management and Regulatory Review (DRMRR)
• CBER Title 21 Vacancy Announcement – Lead Management Analyst (Retention and Recognition Team Lead), AD-0343-Band C, Office of Management (OM), Division of Human Capital (DHC), Management Services Branch (MSB)

Workshops, Meetings & Conferences

May

• Blood Products Advisory Committee Meeting
  May 9, 2024
• Vaccines and Related Biological Products Advisory Committee Meeting
  May 16, 2024